These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11019985)

  • 1. Detection of unexpected lupus anticoagulant during preparation of normal pooled plasma (NPP) from healthy volunteers.
    Ghosh K; Shetty S; Mohanty D
    Thromb Haemost; 2000 Sep; 84(3):519-21. PubMed ID: 11019985
    [No Abstract]   [Full Text] [Related]  

  • 2. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
    Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
    Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
    [No Abstract]   [Full Text] [Related]  

  • 3. An improved method for lupus anticoagulant detection.
    Alonso I; Vandermijnsbrugge F; Vanremoortele E; Bradstreet C; Efira A; Cantinieaux B
    Haematologica; 2005 Apr; 90(4):564-5. PubMed ID: 15820959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
    Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
    Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 7. Lupus anticoagulant: case-based external quality assessment.
    van den Besselaar AM; Devreese KM; de Groot PG; Castel A
    J Clin Pathol; 2009 Aug; 62(8):731-4. PubMed ID: 19638545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulant assays.
    Messmore H; Fabbrini N; Hoppensteadt D; Larach F; Fareed J
    Semin Thromb Hemost; 1994; 20(1):79-88. PubMed ID: 8059237
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of lupus anticoagulant in multiparous women in Benin City, Nigeria.
    Awodu OA; Ejele OA; Shokunbi WA; Enosolease ME
    Niger Postgrad Med J; 2003 Mar; 10(1):19-22. PubMed ID: 12812147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays.
    Liestøl S; Wisløff F
    Thromb Res; 2005; 115(6):509-17. PubMed ID: 15792683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To mix with pooled normal plasma or not to mix: a comparative study of 2 approaches for assessing lupus anticoagulant inhibitory activity in the dilute Russell viper venom method.
    Aboud M; Roddie C; Ward C; Coyle L
    Clin Chem; 2007 Jan; 53(1):143-5. PubMed ID: 17202500
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference interval mean clotting times should not be used to calculate lupus anticoagulant mixing test ratios unless they match the normal pooled plasma clotting time.
    Moore GW
    Thromb Res; 2017 Nov; 159():16-18. PubMed ID: 28946004
    [No Abstract]   [Full Text] [Related]  

  • 15. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
    Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
    Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reference values for the blood coagulation tests in Mexico: usefulness of the pooled plasma from blood donors].
    Calzada-Contreras A; Moreno-Hernández M; Castillo-Torres NP; Souto-Rosillo G; Hernández-Juárez J; Ricardo-Moreno MT; Sánchez-Fernández MG; García-González A; Majluf-Cruz A
    Rev Invest Clin; 2012; 64(5):437-43. PubMed ID: 23544306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant.
    Rosborough TK; Shepherd MF
    Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of low levels of lupus anticoagulant antibodies.
    Villa P; Mira Y; Ferrando F; Vayá A; Aznar J
    Thromb Res; 2005; 116(5):447-9. PubMed ID: 15925399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.